Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines

Blood

Volumn 87, Issue 3, 1996, Pages 1147-1154

  MacDonald, Ian ^b   Wang, Hong ^b   Grand, Roger ^b   Armitage, Richard J ^b   Fanslow, William C ^b   Gregory, Christopher D ^b   Gordon, John ^a  

^a Medical School   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE INDUCTION; GROWTH DISORDER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030042826     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1147.bloodjournal8731147     Document Type: Article

References (31)

1. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen-dnven selection in germinal centres. Nature 342:929, 1989
2. Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB, Lipinski M: Identification of a subset of normal B cells with a Burkitt's-lymphoma (BL)-like phenotype. J Immunol 139:313, 1987
3. Tsujimolo Y, Cossman J, Jaffe E, Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440, 1987
4. Korsemeyer SJ: Bcl-2: A represser of lymphocyte death. Immunol Today 13:285, 1992
5. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905, 1991
6. Berard C, O' Conor GT, Thomas LB, Torloni H: Histopathological definition of Burkitt's tumour. Bull World Health Organ 40:601, 1969
7. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickmson AB: Activation of Epstein-Barr-virus-latent genes protects human B cells from death by apoptosis. Nature 349.612, 1991
8. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55:133, 1990
9. Gregory CD, Rowe M, Rickinson AB: Different Epstein-Barr-virus-B-cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71:1481, 1990
10. Gregory CD, Milner AE: Regulation of cell survival in Burkitt lymphoma: Implications from studies of apoptosis following cold-shock treatment Int J Cancer 57:419. 1994
11. Holder MJ, Wang H, Milner AE, Casamajor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD. Gordon J: Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 23:2368, 1993
12. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr-virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
13. Milner AE, Johnson GD, Gregory CD: Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2-dependem and -independent mechanisms. Int J Cancer 52:636, 1992
14. Altiok A, Bejarano MT, Ruscetti F, Altiok E, Klein G, Klein E: Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines. Growth Factors 4:117, 1991
15. Altiok A, Bejarano MT, Klein G, Klein E: Effect of TGF-beta-1 on the EBV-induced transformation of human lymphocyte cultures. Int J Cancer 50:772, 1992
16. Altiok A, Ehlin-Henriksson B, Klein E: Correlation between the growth-inhibitory effect of TGF-beta-1 and phenotypic characteristics in a panel of B-cell lines. Int J Cancer 55:137, 1993
17. Massagué J, Attisano L, Wrana JL: The TGF-β family and its composite receptors. Trends Cell Biol 4:172, 1994
18. 1 to S transition, but not activation of human B lymphocytes. Exp Cell Res 171-213, 1987
19. INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257, 1994
20. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59, 1994
21. Ewen ME, Sluss HK, Whitehouse LL, Livinston DM: TGF-beta inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009, 1993
22. 1 cyclins. Cell 73.1059, 1993
23. Warner GL, Ludlow JW, Nelson DA, Gaur A, Scott DW: Anti-immunoglobulin treatment of munne B-cell lymphomas induces active transforming growth factor-beta but pRB hypophosphorylation is transforming growth factor-beta independent. Cell Growth Differ 3:175, 1992
24. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH: Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:274, 1992
25. Vuist WMJ, Levy R, Maloney DG: Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of Bcl-2 protein. Blood 83:899, 1994
26. Kumar A, Rogers T, Maizel A, Sharma S: Loss of transforming growth factor β1 receptors and its effects on the growth of EBV-transformed human B cells. J Immunol 147:998, 1991
27. Beckwith M, Ruscetti FW, Sing GK, Urba WJ, Longo DL: Anti-IgM induces transforming growth factor-β sensitivity in a human B-lymphoma cell line: Inhibition of growth is associated with a downregulation of mutant p53. Blood 85:2461, 1995
28. Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB: TGF-β and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 154-1634, 1995
29. Santos-Argumedo L, Gordon J, Heath AW, Howard M: Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest. Cell Immunol 156:272, 1994
30. Milner A, Grand RJA, Waters CM, Gregory CD: Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene 8:3385, 1993
31. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 25:1352, 1995